logo
ResearchBunny Logo
Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation

Medicine and Health

Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation

X. Xu, T. Xie, et al.

This groundbreaking research by Xiaoyan Xu and colleagues reveals how Hsc70 can significantly enhance the efficacy of immune checkpoint therapies by promoting the degradation of PD-L1. By inhibiting the CMTM6-PD-L1 interaction, Hsc70 plays a crucial role in reducing tumor growth and improving anti-tumor immunity, particularly when paired with the Hsp90α/β inhibitor AUY-922.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny